DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vistide (Cidofovir) - Published Studies

 
 



Vistide Related Published Studies

Well-designed clinical trials related to Vistide (Cidofovir)

Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study. [2009.10]

Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study. [2008.07]

Well-designed clinical trials possibly related to Vistide (Cidofovir)

Cytomegalovirus. [2014]

First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses. [2012]

Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art. [2009.05]

Treatment results in adult-onset recurrent respiratory papillomatosis. [2009]

Antiviral agents for the treatment of recurrent respiratory papillomatosis: a systematic review of the English-language literature. [2007.06]

Other research related to Vistide (Cidofovir)

Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial. [2014]

Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir. [2011.09]

Intravenous cidofovir for resistant cutaneous warts in a patient with psoriasis treated with monoclonal antibodies. [2011.08]

Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis. [2011.04]

Novel method of intralesional cidofovir injection into laryngotracheal papillomata. [2011.04]

Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion. [2011.02]

Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection. [2011.01]

Efficacy of cidofovir in recurrent juvenile respiratory papillomatosis. [2010.11]

Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma. [2010.10.09]

Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach. [2010.10]

Mitochondrial changes in cidofovir therapy for BK virus nephropathy. [2010.06]

Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach. [2010.05.07]

Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. [2010.05]

Mucosal bridge and pitting of the true vocal fold: an unusual complication of cidofovir injection. [2010.04]

Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis. [2010.04]

[The schedule of intralesional papillomatosis treatment with cidofovir] [2010.03]

Progressive multifocal leukoencephalopathy developed in incomplete Heerfordt syndrome, a rare manifestation of sarcoidosis, without steroid therapy responding to cidofovir. [2010.02]

Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin. [2010.02]

Effects of cidofovir on human papillomavirus-positive cervical cancer cells xenografts in nude mice. [2010]

Cidofovir does not prevent caprine herpesvirus type-1 neural latency in goats. [2010]

Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet. [2009.11]

Development of herpes simplex virus stomatitis during receipt of cidofovir therapy. [2009.10.15]

[Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children] [2009.09]

In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer. [2009.09]

Safety and tolerability of cidofovir in high-risk pediatric patients. [2009.08]

Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. [2009.07.15]

Cidofovir: clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesions. [2009.06]

Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infections. [2009.06]

Adenovirus infection and treatment with cidofovir in children after liver transplantation. [2009.06]

Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin). [2009.06]

Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient. [2009.06]

Decreased viral load and symptoms of polyomavirus-associated chronic interstitial cystitis after intravesical cidofovir treatment. [2009.05.01]

Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children. [2009.05]

Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: case report and review of literature. [2009.04]

Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis. [2009.03]

The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients. [2009.03]

Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox. [2009.01]

Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone. [2009]

Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease. [2009]

Assessing the efficacy of cidofovir against herpesvirus-induced genital lesions in goats using different therapeutic regimens. [2008.11]

Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation. [2008.11]

Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. [2008.11]

Topical cidofovir for severe warts in a patient affected by AIDS and Hodgkin's lymphoma. [2008.10]

Biopsy-proven adenoviral diarrhea responding to low-dose cidofovir. [2008.10]

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. [2008.09.12]

Cidofovir modulated gene expression in recurrent respiratory papillomatosis. [2008.09]

Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin). [2008.08.27]

Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. [2008.08]

Follow-up of HPV DNA copy number in cidofovir therapy of recurrent respiratory papillomatosis. [2008.07]

Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis. [2008.07]

Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. [2008.05.20]

Adult intralesional cidofovir therapy for laryngeal papilloma: a 10-year perspective. [2008.05]

Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir. [2008.05]

Successful treatment of florid cutaneous warts with intravenous cidofovir in an 11-year-old girl. [2008.05]

BK virus-associated nephropathy in a kidney transplant recipient successfully treated with cidofovir, the first case in Japan. [2008.04]

Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment. [2008.04]

Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy. [2008.04]

[Extensive oral condylomas treated by in situ cidofovir injection in an HIV patient] [2008.04]

Cidofovir injection for recurrent laryngeal papillomatosis. [2008.03]

High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. [2008.03]

Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats. [2008.02]

Cidofovir: to use or not to use? [2008.02]

Histologic review of cidofovir-treated recurrent respiratory papillomatosis. [2008.02]

Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model. [2008.01]

Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature. [2008]

Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. [2007.09]

Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection. [2007.09]

In vivo imaging of cidofovir treatment of cowpox virus infection. [2007.09]

Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis. [2007.08]

[Progressive multifocal leukoencephalopathy in a non-AIDS patient: high efficiency of combined cytarabine and cidofovir] [2007.07]

Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient. [2007.06.15]

Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient. [2007.06]

Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. [2007.06]

Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. [2007.06]

[Intravesical cidofovir--instillation therapy for polyomavirus-associated hemorrhagic cystitis after bone marrow transplantation] [2007.05]

Cidofovir is effective against caprine herpesvirus 1 infection in goats. [2007.05]

[Disseminated molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus: efficacy of cidofovir] [2007.05]

Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. [2007.04.16]

Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. [2007.03]

Antiviral activity of HPMPC (cidofovir) against orf virus infected lambs. [2007.03]

Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis. [2007.02]

Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. [2007.01]

Intralesional Cidofovir application in recurrent laryngeal papillomatosis. [2007.01]

Potent inhibition of genital herpesvirus infection in goats by cidofovir. [2007]

Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy. [2007]

Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype. [2006.12]

3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis. [2006.11]

Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection. [2006.11]

Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(iso-butylcyanoacrylate) nanocapsules. [2006.10.31]

Anterior uveitis associated with treatment with intravenous cidofovir in kidney transplant patients with BK virus nephropathy. [2006.10]

Cidofovir administered with radiation displays an antiangiogenic effect mediated by E6 inhibition and subsequent TP53-dependent VEGF repression in HPV18+ cell lines. [2006.10]

Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis. [2006.09]

Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection. [2006.09]

Office-based intralesional cidofovir injections for nasal septal papilloma: a pilot study. [2006.07]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017